TRU:NYSETransUnion Analysis

TransUnion trades at $70.60, marginally above its DCF‑derived fair value of $69.58, but still offers a ~34% upside to the consensus 12‑month target of $95. Technical indicators are bearish – the stock sits beneath its 20‑day (75.24), 50‑day (78.36) and 200‑day (84.46) moving averages, RSI is at 38 and MACD shows a bearish divergence. Fundamentally, the company delivered a strong Q4 beat, posted 13% revenue growth, and raised forward EPS guidance to $5.87, compressing the forward P/E to 12 versus a 30‑year‑average industry P/E of 16. The recent acquisition of a 68% stake in TransUnion de México and a lower‑priced mortgage origination score demonstrate strategic expansion and pricing discipline. Dividend sustainability looks solid with a 19.8% payout ratio, ample operating cash flow and a modest 0.72% yield. Analyst sentiment remains positive (Buy recommendation, 20 analysts) and the “Greed” sentiment on the Fear & Greed Index (72.48) supports a risk‑on bias. However, the stock’s beta of 1.59 and 30‑day volatility of 57% signal heightened market sensitivity, and the current bearish trend suggests caution in the near term.
Overall, while short‑term price pressure may persist, the combination of attractive forward valuation, growth‑oriented earnings guidance, and strategic initiatives positions TransUnion as a compelling medium‑to‑long‑term buy, provided investors are comfortable with its elevated volatility and regulatory exposure.